Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

TRADER TALK VIDEO GALLERY

» More

Current DateTime: 07:41:30 25 Nov 2009
LinksList Documentid: 30483322
Expiration DateTime: 11/25/2009 7:42:22 AM

TRADER TALK RSS FEED

» Help

Current DateTime: 07:41:31 25 Nov 2009
LinksList Documentid: 30456179
powered by digg
Trader Talk Video Gallery
CNBC's Bob Pisani reports on the trading day from the NYSE.
CNBC's Bob Pisani reports on the trading day from the NYSE.
Bob Pisani reports on the trading day from the NYSE.
Bob Pisani reports on the trading day from the NYSE.
Bob Pisani reports on the trading day from the NYSE.
Bob Pisani reports on the trading day from the NYSE
CNBC's Bob Pisani reports on the trading day from the NYSE.
CNBC's Bob Pisani reports on the trading day from the NYSE.

Trader Talk

Text Size
Apr.23
9:35 AM ET
Wednesday, 23 Apr 2008
Boeing's Nice Earnings vs. Weak Water IPO

Futures about flat as oil is at least down a bit this morning. Earnings were mixed, and an IPO pricing was a bit disappointing.

Boeing [BA  Loading...      ()   ] earnings better than expected: $1.62 vs. $1.35 est. Reaffirmed 2008 guidance of $5.70-$5.85.  For 2009, guidance of $6.80-$7.00 is about in line with expectations.

Ryder [R  Loading...      ()   ] handily beat earnings estimates, and raised full year forecast to $4.55-4.75.

How much money can an airline lose? Delta [DAL  Loading...      ()   ] lost $6.4 billion, or $16.15 a share. Its merger partner Northwest [NWA  Loading...      ()   ] reported a net loss of $4.1 billion, or $15.78 a share.

Trade with CNBC's Experts

What happened to American Water Works? [AWK  Loading...      ()   ] The IPO price talk was 64 million shares at $24-$26; it priced 58 million at $21.50. This IPO had been postponed before, in November, as the company cited unfavorable market conditions.

Water is certainly a hot space right now. I have heard that valuation was the concern (i.e., it was priced too high). Also heard that retail street allocation was large -- which means institutions did not load up).

Eaton priced 17.5 m shares at $84 a share, which will be used to pay off prior aquisitions. They also affirmed their full year operating earnings.

GlaxoSmithKline [GSK  Loading...      ()   ] is paying big for anti-aging research. They are buying Sirtris Pharmaceuticals [SIRT  Loading...      ()   ] for $720 million in cash, or $22.50 per share.

This price represents an 84 percent premium over SIRT's closing price yesterday.
Two things are going on here:
1) this company is the leading research outfit in anti-aging research through very promising chemical compounds (sirtuins) that appear to slow the aging process (they are initially being tested for diabetes), and
2) big pharmaceutical companies are desperate for new drugs and novel technologies; expect more European pharma companies to sniff around and buy U.S. biotechs with their inflated Euros.

I will have the founder and CEO of Sirtris, Christoph Westphal, on Closing Bell at 3:20pm ET.


Questions?  Comments? 

© 2009 CNBC, Inc. All Rights Reserved

Tools:
PrintEmailAdd This share icon
Next Post
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 05:21:40 25 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:03:47 25 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 02:05:46 25 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:02:04 25 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters